Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Boosts Jacobs Solutions Stake to 7.7%
BlackRock, Inc. has reported an increased beneficial ownership of 7.7% in Jacobs Solutions Inc. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Sotera Health to 6.2%
BlackRock, Inc. has disclosed an increased beneficial ownership of 6.2% in Sotera Health Co., holding over 17.7 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Devon Energy Stake to 7.9%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 7.9% beneficial ownership stake in Devon Energy Corporation as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Hilton Stake to 8.3%
BlackRock, Inc. has reported an 8.3% beneficial ownership stake in Hilton Worldwide Holdings Inc., holding over 19 million shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.2% Stake in Hallador Energy
BlackRock, Inc. has reported a 5.2% beneficial ownership stake in Hallador Energy Co., totaling 2,270,441 shares of common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Guardian Pharmacy Stake Disclosure
BlackRock, Inc. filed an amended Schedule 13G disclosing its beneficial ownership of 4.2% of Guardian Pharmacy Services, Inc. Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains 5.1% Stake in WPP PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in WPP PLC as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Akamai Stake to 7.0%
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 7.0% beneficial ownership stake in Akamai Technologies Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in MBX Biosciences
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in MBX Biosciences Inc. common stock, held for ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.9% Stake in LENZ THERAPEUTICS
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.9% of LENZ THERAPEUTICS, INC.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Kodiak Gas Services to 14%
BlackRock, Inc. has increased its beneficial ownership in Kodiak Gas Services, Inc. to 14.0% of common stock, holding 11,969,209 shares.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in iShares Bond ETF
BlackRock, Inc. reported an 8.3% beneficial ownership in the iShares Core Universal USD Bond ETF, holding over 61 million shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 6.1% Stake in iShares GNMA Bond ETF
BlackRock, Inc. has reported a 6.1% beneficial ownership stake in iShares GNMA Bond ETF, holding 547,788 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Stake in Molson Coors
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Molson Coors Beverage Co. Class B Stock, totaling 10,217,118 shares.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.01% Stake in Sight Sciences
BlackRock, Inc. has reported a beneficial ownership of 5.01% of Sight Sciences, Inc.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Repay Holdings to 6.1%
BlackRock, Inc. has disclosed a 6.1% beneficial ownership stake in Repay Holdings Corporation's Class A Stock, as detailed in its latest Schedule 13G filing.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in Red Cat Holdings
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.3% of Red Cat Holdings, Inc.'s common stock.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in Foreign Trade Bank
BlackRock, Inc. has reported a 5.6% beneficial ownership stake in FOREIGN TRADE BANK OF LATIN AMERICA INC as of December 31, 2025, held for passive investment purposes.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in ORIC Pharmaceuticals
BlackRock, Inc. has reported a 5.6% passive ownership stake in ORIC Pharmaceuticals Inc., holding 5,473,145 shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Reports 6.7% Stake in Quantum Computing Inc.
BlackRock, Inc. has disclosed a 6.7% beneficial ownership stake in Quantum Computing Inc., holding over 15 million common shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 4.9% Stake in FIGS, Inc. Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership in FIGS, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Ellington Financial to 15.3%
BlackRock, Inc. has reported an increased beneficial ownership of 15.3% in Ellington Financial Inc.'s common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Customers Bancorp Stake to 13.6%
BlackRock, Inc. has increased its beneficial ownership in Customers Bancorp Inc. to 13.6% of common stock, holding 4,634,097 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Oklo Inc. Class A to 9.2%
BlackRock, Inc. has reported an increased beneficial ownership of 9.2% in Oklo Inc. Class A shares, holding 14,419,350 shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in Charter Communications
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.1% of Charter Communications, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Boosts Stake in BrightSpring Health to 9.9%
BlackRock, Inc. has disclosed a 9.9% beneficial ownership stake in BrightSpring Health Services Inc., holding over 18 million common shares.
NYSE
SCHEDULE 13G/A: BlackRock Amends Anteris Technologies Stake to 4.9%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% beneficial ownership in Anteris Technologies Global Corp's common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 8.1% Stake in Archer Aviation
BlackRock, Inc. has disclosed an 8.1% beneficial ownership stake in Archer Aviation Inc.'s Class A Stock, holding 52,989,964 shares.
NYSE
SCHEDULE 13G/A: BlackRock Amends Axon Enterprise Stake to 9.5%
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 9.5% beneficial ownership stake in Axon Enterprise Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in BRC Inc.
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in BRC Inc.'s Class A Stock as of December 31, 2025.